Clinical Trial Detail

NCT ID NCT03511664
Title Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer (VISION)
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Endocyte
Indications

prostate cancer

Therapies

177Lu-PSMA-617

Age Groups: adult senior

No variant requirements are available.